
    
      Participants were randomized in a 3-way crossover design and received, in random order,
      Zegerid OTC Capsules (20 mg omeprazole and 1100 mg sodium bicarbonate), Prilosec OTC Tablets
      (20 mg-equivalent omeprazole), and Placebo Capsules. Participants received each treatment for
      11 days. There was a minimum of a 2-week washout period between treatment arms.
    
  